The European Green Deal and nephrology: a call for action by the European Kidney Health Alliance.

circular dialysis concept ecology environment green nephrology waste control

Journal

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402

Informations de publication

Date de publication:
04 05 2023
Historique:
received: 07 03 2022
medline: 5 5 2023
pubmed: 29 4 2022
entrez: 28 4 2022
Statut: ppublish

Résumé

The world faces a dramatic man-made ecologic disaster and healthcare is a crucial part of this problem. Compared with other therapeutic areas, nephrology care, and especially dialysis, creates an excessive burden via water consumption, greenhouse gas emission and waste production. In this advocacy article from the European Kidney Health Alliance we describe the mutual impact of climate change on kidney health and kidney care on ecology. We propose an array of measures as potential solutions related to the prevention of kidney disease, kidney transplantation and green dialysis. For dialysis, several proactive suggestions are made, especially by lowering water consumption, implementing energy-neutral policies, waste triage and recycling of materials. These include original proposals such as dialysate regeneration, dialysate flow reduction, water distillation systems for dialysate production, heat pumps for unit climatization, heat exchangers for dialysate warming, biodegradable and bio-based polymers, alternative power sources, repurposing of plastic waste (e.g. incorporation in concrete), registration systems of ecologic burden and platforms to exchange ecologic best practices. We also discuss how the European Green Deal offers real potential for supporting and galvanizing these urgent environmental changes. Finally, we formulate recommendations to professionals, manufacturers, providers and policymakers on how this correction can be achieved.

Identifiants

pubmed: 35481547
pii: 6575047
doi: 10.1093/ndt/gfac160
doi:

Substances chimiques

Dialysis Solutions 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1080-1088

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the ERA.

Auteurs

Raymond Vanholder (R)

European Kidney Health Alliance, Brussels, Belgium.
Nephrology Section, Department of Internal Medicine and Paediatrics, University Hospital Ghent, Gent, Belgium.

John Agar (J)

Renal Services, University Hospital Geelong, Barwon Health, Geelong, Victoria, Australia.

Marion Braks (M)

European Kidney Health Alliance, Brussels, Belgium.

Daniel Gallego (D)

European Kidney Health Alliance, Brussels, Belgium.
European Kidney Patients Federation, Wien, Austria.

Karin G F Gerritsen (KGF)

Department of Nephrology and Hypertension, University Medical Centre Utrecht, Utrecht, The Netherlands.

Mark Harber (M)

University College London, Department of Renal Medicine, London, UK.

Edita Noruisiene (E)

European Kidney Health Alliance, Brussels, Belgium.
European Dialysis and Transplant Nurses Association-European Renal Care Association, Hergiswil, Switzerland.

Jitka Pancirova (J)

European Dialysis and Transplant Nurses Association-European Renal Care Association, Hergiswil, Switzerland.

Giorgina B Piccoli (GB)

Néphrologie, Centre Hospitalier Le Mans, Le Mans, France.

Dimitrios Stamatialis (D)

Advanced Organ Bioengineering and Therapeutics-Technical Medical Centre, University of Twente, Enschede, The Netherlands.
Department of Nephrology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.

Fokko Wieringa (F)

European Kidney Health Alliance, Brussels, Belgium.
Department of Nephrology and Hypertension, University Medical Centre Utrecht, Utrecht, The Netherlands.
imec the Netherlands, Holst Centre, Eindhoven, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH